Stalevo for Parkinson's disease.
D002230:Carbidopa / Q000008:administration & dosage / Q000627:therapeutic use*; D002396:Catechols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003967:Diarrhea / Q000139:chemically induced; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000627:therapeutic use*; D009325:Nausea / Q000139:chemically induced; D009570:Nitriles; D010300:Parkinson Disease / Q000188:drug therapy*
D002396:Catechols; D004338:Drug Combinations; D009570:Nitriles; C481098:Stalevo; D007980:Levodopa; C071192:entacapone; D002230:Carbidopa